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Background: It is becoming increasingly necessary for community health centers to make rehabilitation services
available to patients with osteoarthritis of the knee. However, for a number of reasons, including a lack of expertise,
the small size of community health centers and the availability of only simple medical equipment, conventional
rehabilitation therapy has not been widely used in China. Consequently, most patients with knee osteoarthritis seek
treatment in high-grade hospitals. However, many patients cannot manage the techniques that they were taught in
the hospital. Methods such as acupuncture, tuina, Chinese medical herb fumigation-washing and t’ai chi are easy to
do and have been reported to have curative effects in those with knee osteoarthritis. To date, there have been no
randomized controlled trials validating comprehensive traditional Chinese medicine for the rehabilitation of knee
osteoarthritis in a community health center. Furthermore, there is no standard rehabilitation protocol using
traditional Chinese medicine for knee osteoarthritis. The aim of the current study is to develop a comprehensive
rehabilitation protocol using traditional Chinese medicine for the management of knee osteoarthritis in a
community health center.
Method/design: This will be a randomized controlled clinical trial with blinded assessment. There will be a 4-week
intervention utilizing rehabilitation protocols from traditional Chinese medicine and conventional therapy.
Follow-up will be conducted for a period of 12 weeks. A total of 722 participants with knee osteoarthritis will be
recruited. Participants will be randomly divided into two groups: experimental and control. Primary outcomes will
include range of motion, girth measurement, the visual analogue scale, and results from the manual muscle,
six-minute walking and stair-climbing tests. Secondary outcomes will include average daily consumption of pain
medication, ability to perform daily tasks and health-related quality-of-life assessments. Other outcomes will include
rate of adverse events and economic effects. Relative cost-effectiveness will be determined from health service
usage and outcome data.
Discussion: The primary aim of this trial is to develop a standard protocol for traditional Chinese medicine, which
can be adopted by community health centers in China and worldwide, for the rehabilitation of patients with knee
osteoarthritis.
Trial registration: Clinical Trials Registration: ChiCTR-TRC-12002538
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Knee osteoarthritis (KOA) increases in prevalence with
age and causes pain, loss of functional independence
and psychological impairment, and reduces the overall
quality of life of affected individuals [1-3]. Based on
epidemiological results, the incidence rate of osteoarthritis
in the Chinese population is approximately 10% and the
number of patients with KOA is greater than 50 million
[4]. KOA has been identified as one of the most serious
diseases that can affect an individual during his or her life-
time. It is a degenerative disorder caused by the interplay of
genetic, metabolic, biochemical and biomechanical factors
and results in pain, swelling and malformation of the knee
joint [5]. KOA is prevalent and chronic and is associated
with physical and psychological dysfunction. It reduces
quality of life by inhibiting or preventing sufferers from
carrying out activities such as walking, climbing stairs,
doing housework, socializing and engaging in outdoor
pursuits [6]. Furthermore, dysfunction due to KOA strongly
influences employment status, productivity [7,8] and in-
creases obesity rates [9], especially among older people.
Pain, swelling, malformation and muscle weakness are
often interrelated, leading to a downward cascade in phys-
ical as well as mental function [10-12].
During rehabilitation, patients with KOA require good
pain control with few adverse events (AEs). Clinical guide-
lines advocate conservative non-drug strategies for the
treatment of KOA [13], such as muscle-strengthening exer-
cises, electromagnetic therapy and acupuncture. These con-
ventional rehabilitation therapies are focused on controlling
pain as well as reducing physical disability and impairment,
while minimizing the potentially harmful side effects
of medication [14]. These therapies can improve KOA
patient outcomes [15], but are often only offered in
high-grade hospitals and not in community health centers
(CHCs). Consequently, the direct and indirect health-care
costs associated with KOA frequently become a major
burden to patients. After their discharge, patients will
often abandon the rehabilitation therapy techniques
they have learned and the KOA will become progressively
worse. Therefore, as the patients aging and comorbidities
increasing, a more convenient, effective, simple and
inexpensive approach to rehabilitation is necessary for
those with KOA.
The use of traditional Chinese medicine (TCM) for
the treatment of KOA has increased substantially. In
Chinese medicine, KOA is considered to originate in
the tendons and bones, but manifests as viscera insuffi-
ciency and biao or branch excess. The invasion of evil
pathogens, due to wind-cold-dampness, is linked to
blood stasis, which then leads to wei zheng and bi zheng
[16]. Wei zheng is treated by viscera reinforcement and
bi zheng is treated by wind-cold-dampness purging and
blood activation.TCM has been used for health care in China for
thousands of years. Some TCM rehabilitation methods,
such as Chinese medical herbal patches, traditional exer-
cises (developed from simplified t’ai chi and yi jinjing) and
acupuncture have been reported to improve KOA in
patients clinically [17-20]. The comprehensive TCM rehabili-
tation protocol (CTCMRP) comprises Chinese medical herb
fumigation-washing (done to dispel wind-cold-dampness
and to activate blood circulation in the knee), traditional
exercise training, acupuncture and bloodletting via
puncture. CTCMRP can enhance muscle strength, improve
balance, reduce knee pain, stimulate the governor vessel
and spine, and can regulate the function of the viscera,
qi and blood in the zang-fu organs.
However, results from randomized controlled trials
examining TCM treatments for KOA are contradictory
and there is no standard rehabilitation protocol for KOA
treatment using TCM (SRPTCM) [21]. Therefore, in the
current study a protocol was designed in which KOA
patients will be treated using CTCMRP in CHCs. The




This will be a cluster randomized controlled trial with
blinded assessment (Figure 1). The trial will comprise a
4-week intervention, using the CTCMRP and conven-
tional therapy (CT), and a 12-week follow-up period. The
protocol will be conducted at CHCs run by the Affiliated
People’s Hospital of Fujian University of Traditional Chinese
Medicine (Fujian province, China), the Comprehensive Trad-
itional and Western Medicine Hospital of Guangdong prov-
ince (Guangdong province, China), the Chengdu Military
Region General Hospital of the Chinese People’s Liberation
Army (Sichuan province, China) and the First Affiliated Hos-
pital of Guangzhou University of Traditional Chinese Medi-
cine (Guangdong province, China). To include a broad
range of patients, this protocol includes CHCs in different
areas. Fujian University of Traditional Chinese Medicine
(FJTCM) is responsible for training and supervising rehabili-
tation therapists at all clinical sites. The evidence-based
medicine center, which will be used for documentation
and data analysis, is an independent site that performs
data monitoring, randomization and statistical evalu-
ation and will be blind to the intervention. Patients
will be recruited through CHC outpatient clinics. The
Human Research Ethics Committee at Fujian Univer-
sity of Traditional Chinese Medicine (Fujian province,
China) approved the study.
Participants
Patients suffering from pain, swelling, muscle weakness
and stiffness of the knee will tested for KOA. All
Figure 1 Study flow chart.
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formed consent prior to beginning baseline assessment
and rehabilitation.
Inclusion criteria
 Participants will have been diagnosed with KOA
according to the criteria in the Guide Diagnosis of
Bone Arthritis (2007) published by the Chinese
Medical Association [22].
 Participants may be male or female and must be
between 40 and 75 years of age.
 Participants will be considered to have early- to
middle-stage KOA.
 Participants will understand the research and will
have signed the informed consent. Symptoms will include pain, swelling, stiffness or
malfunction of the knee according to the assessment
scale.
Exclusion criteria
Patients are excluded if they have:
 severe knee swelling
 a muscle strength of grade 2 or below according to a
manual muscle test
 a history of trauma to the knees
 serious heart, kidney, liver or nervous system
disease, or lower limb gangrene due to diabetes.
 lower limb dysfunction caused by spinal, hip or
ankle joint disease, or prior knee joint surgery
 a tumor of the knee joint
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 received traditional exercise training and/or tuina
for the knee within the last 4 weeks
Recruitment
Outpatients with KOA will be recruited from participating
CHCs in China. All participants will be selected according
to the above inclusion and exclusion criteria. Baseline
measurements will include the general and demographic
data for the subjects, assessment of the knee prior to testing,
medication use, previous treatments, KOA complications
and duration of KOA symptoms. Due to ethical consid-
erations, non-steroidal, anti-inflammatory drugs will be
permitted (and registered) as required for patients with
visual analogue scale (VAS) scores over 5. All patients will
be asked to refrain from seeking other forms of treatment
during the trial. During the follow-up period, patients will
be asked to report whether they have received other forms
of treatment.
Randomization and allocation
Following an epidemiological survey, the CHC randomiza-
tion list for this study will be computer generated using
SAS software (Version 8.2, SAS Institute, Cary, NC, USA)
and concealed at an independent evidence-based medical
center. Employees at the medical center will also be blinded
to the intervention. Treatment allocation will start when it
has been determined that a study participant meets the in-
clusion criteria and has signed the informed consent.
The CHC randomization program will assign subjects to
each group and each participant’s group number will be
displayed (CTCMRP versus CT rehabilitation) on the back
of the form. Baseline measurements will not be viewed
until the end of the study to ensure blinded assessment.
The allocation list will be protected and held by FJTCM. In
the event of an emergency, the individual’s randomization
code and group allocation can be identified. Therapists at
each participating CHC will provide treatment, as usual, to
patients who are not eligible or willing to participate.
Sample size
In cluster randomized trials, the inspection efficiency
comes from the random unit number (cluster number)
rather than the size. There are two important factorsTable 1 Baseline descriptive data
Data Content
General data Agent of the person who conducted t
family members and the patient’s tele
Demographic data of subject Gender, age, nationality, level of educa
Assessment of knee before test Visual analogue scale (VAS), knee girth
ability, walking distance, comprehensiv
taken, activities of daily living (ADL), qu
Other Complications, medication use, previouwhen estimating the sample number: (1) The number
within each cluster group and (2) the intraclass correl-
ation coefficient estimate. The total number of subjects
(n) from all of the CHCs was calculated according to




π1 1−π1ð Þ þ π2 1−π2ð Þ½  1þ m−1ð Þρ½ 
π1−π2ð Þ2
In a trial test of this protocol, the curative effect rate
after rehabilitation of KOA was 70% in the control
group (π1) and 82.3% in the experimental group (π2);
this will be used as the main index. The number of
qualified participants recruited from each CHC (m)
will not be less than 17. Prior data indicate that the
intra-CHC correlation coefficient (ρ) is likely to be, at
most, 0.020, andμα = 0.05 and μβ = 0.10.
There are 38 CHCs. Based on the formula, each group
(control and experimental) will comprise 323 participants.
A total number of 722 subjects will be included to allow
for a dropout rate of 10%.
Ethical issues
The Ethics Committee of the FJTCM approved this proto-
col (Approval No. 2012–031). Each participating center will
obtain local institutional review board approval. All
study participants will sign an informed consent sheet
prior to participation.
Baseline measurements
Baseline descriptive data will be obtained via a ques-
tionnaire (Table 1).
Interventions
The participants in the experimental group will undergo
CTCMRP rehabilitation treatment. This consists of Chinese
medical herb fumigation-washing, traditional exercises
(developed from simplified t’ai chi and yi jinjing), acupunc-
ture and tuina. Patients in the control group will undergo
CT rehabilitation including physical factor therapy and
kinesitherapy. The duration of rehabilitation will be 4 weeks,
which is a common duration in clinical practice. Duringest, test start date, the patient’s address, name of accompanying
phone number
tion, profession, height and weight
, knee’s range of motion (ROM), manual muscle test (MMT), stair-climbing
e effect, average daily amount of non-steroidal anti-inflammatory drugs
ality of life (QOL), safety assessments and economic evaluation
s treatment and duration of KOA symptoms
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performance, exercise intensity and will progress the exer-
cises, if necessary.Health education
Two strategies will be used for health education: (1)
Educational brochures on KOA, published by FJTCM, will
be sent to participants. Information in these brochures
will include the concept, epidemiology, etiology, common
symptoms, diagnosis, treatments and precautions that
should be taken. (2) The rehabilitation therapist will
introduce and explain the contents of the educational
brochures to all participants in person.
The aim is to help participants learn about and under-
stand KOA and to implement strategies to help alleviate
the disease. Moderate activity, aerobic training (swimming),
avoidance of long periods of running or jumping, decreas-
ing or avoiding climbing stairs, and reducing weight if
necessary, can all help to improve KOA.Experimental group
The experimental group will be treated according to the
CTCMRP (Table 2).
In all cases, Chinese medical herb fumigation-washing
with traditional exercises (to a basic prescription) will
be used. If there is significant swelling in the joint,
basic rehabilitation plus cupping and bloodletting will
be used. When there is a significant decrease in joint
strength, basic rehabilitation plus tuina will be used.
When there is significant joint pain, basic rehabilitation
plus acupuncture will be used.Chinese medical herb fumigation-washing
The right or left knee joint will be washed twice daily, for
6 days, with a decoction of hai tong pi [24]. The recipe for
this is: Erythrina indica Lam (15 g), moxa (15 g), Phryma
leptostachya (15 g), Lycopodium clavatum (15 g), radix
aconiti (10 g), radix aconiti agrestis (10 g), Pericarpium
zanthoxyli (10 g), radix angelicae (10 g), radix clematidis
(10 g), cassia twig (10 g), safflower carthamus (5 g) and
Ligusticum wallichii (5 g). Patients will undergo a 6-day
course of treatment on four separate occasions (Table 3).Table 2 TCM rehabilitation based on syndrome using approp
Symptom T
Diagnosis of KOA and inclusion and exclusion criteria B
e
Swelling (mild to moderate by knee girth) B
Weak muscle strength (over 3 degrees by MMT) B
Pain (over 5 by VAS) BTraditional exercises
Simplified t’ai chi and yi jinjing exercises will be performed
twice daily with each patient completing one set of 15 repe-
titions for both knees (Table 3).
Cupping and bloodletting intervention
Patients will undergo cupping as well as being punctured
for bloodletting. This will be done twice weekly, at points
ST 34 and SP 10, using a percusso-punctator. This will
not be done in patients with skin ulcers, dermatitis or
hemophilia.
Tuina
This treatment is based on the theory of meridians and will
be done once a day (15 repetitions of 3 to 5 minutes each)
as in clinical practice (Table 4).
Acupuncture
Patients with a pain score over 3, according to the VAS
scale, will undergo acupuncture. While the patient is
lying down, needles will be inserted into the following
acupuncture points: Ex-LE 5, Ex-LE05, Ex-LE 2 and Ashi.
The treatment will last 30 minutes and will be carried once
per day. Single-use Huatuo needles (0.35 × 40 mm) will be
used and will be disposed of into a bedside sharps container
upon completion of treatment.
Control group
The control group will be treated with physical factor re-
habilitation and kinesitherapy [22,25].
Thermal design power
Participants will be asked to undergo Te Ding Dian Ci
Pu (TDP, a machine that can release specific frequency
of electromagnetic wave to treat disease) for at least
30 minutes per day. The distance between the TDP and
the knee must be from 30 cm to 50 cm.
Kinesitherapy
Kinesitherapy is designed to strengthen lower limb mus-
cles and incorporates exercises commonly used in clin-
ical practice. It is based on clinical trials showing that
such exercise programs can reduce pain and improve
function [26]. The aim of kinesitherapy is to strengthenriate technology
CM rehabilitation treatment
asic rehabilitation: Chinese medical herb fumigation-washing + traditional
xercises (developed from simplified t’ai chi and yi jinjing)
asic rehabilitation + bloodletting by puncturing and cupping
asic rehabilitation + tuina
asic rehabilitation + acupuncture
Table 3 Traditional exercise intervention (developed from simplified t’ai chi and yi jinjing)
Phase Description and progression
Phase 1: foot and heel jolt (i) Stand at attention, heel lift up and look forward for 10 seconds
(ii) Move the heel back down, tap the ground slightly and keep looking forward
Phase 2: rotate knee (i) Stand at attention, slightly bend knees, put hands on the ipsilateral knees and look forward
(ii) Circular movement of knee
Phase 3: heel kick (i) Lie down with leg bent and hands lying naturally at the side of the body
(ii) Bend at the hip joint and at the knees, extend the back of the ankle for 15 seconds, kick up the heel while
moving the toes toward the shin (plantar flexion) and straighten the knee as far as possible. Do this one leg at a time
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the knee. Participants will do this twice daily under the
direction of the therapist (Table 5).Timelines
Project funding was approved in July 2012 and commenced
in October 2012. Ethics approval was obtained from the
Medical Ethics Committee of FJTCM in September 2012.
Recruitment commenced in October 2012 and will be
completed in October 2013. The trial is due for comple-
tion in October 2015 at which time all participants will
have completed the 3-month follow-up. Outcomes will
be assessed at baseline, and at 4-, 10- and 12-weeks
post-baseline. Telephone contact and follow-up clinic
visits will be used to assess participant adherence to
the study protocol.Table 5 Kinesitherapy
Intervention Description
Passive movement (i) The patient sits on a bed with the limb hanging
over the edge of a bed. A rolled towel or pad is
placed under the shallow depression at the back
of the knee joint (popliteal fossa).Follow-up
During the 12-week follow-up period, trained personnel
will contact the participants each week via telephone.
Participants will be asked about the KOA and whether
they have received other treatments. Participants will be
asked to attend a follow-up clinic at 6 and 12 weeks to
assess pain, swelling, range of motion, muscle strength,
average walking distance, stair climbing ability, activities
of daily living (ADL), quality of life (QOL) and medica-
tion usage.(ii) The therapist holds the bottom (distal) of the
lower leg and pulls toward the foot for 10 seconds.
This is repeated five times consecutively.
(iii) The therapist uses his or her hands to flex
and extend the knee. Patients will be informedOutcome assessment
Outcome measures have been selected based on those
recommended for clinical trials of KOA [27] (Table 6).Table 4 Tuina intervention
Location Description and progression
Bladder meridians Thumb and fingers rub the points from BL 37 to BL 56
Stomach meridians Thumb and fingers rub the points from ST 34 to ST 36
Spleen meridians Thumb and fingers rub the point from SP 9 to SP 10
Around the knee Push the muscle and warm using the palm of
the hand and the base of the thumb (the thenar
eminence) repeatedlyPrimary outcomes
Average knee pain will be self-assessed using a 100 mm
visual analogue scale (VAS) with terminal descriptors of
‘no pain’ and ‘worst pain possible’. The VAS pain meas-
urement has demonstrated reliability in KOA [27].
Knee girth will be determined using a flexible plastic
measuring tape to measure the transverse plane circumfer-
ence of the knee at the mid-patellar height, with the patient
in a supine position. Girth measurement has shown accept-
able reliability for determination of gross changes in knee
swelling after knee surgery [28].
The knee’s range of motion (ROM) will be measured
using a standard long-arm goniometer. To determine knee
flexion ROM, patients will be asked to slide the heel ac-
tively towards the buttocks and maximal active knee flexion
will be measured. Knee ROM in patients with KOA has
been shown to be adequately reliable with a coefficient of
0.96 for flexion and 0.81 for extension [29].
The manual muscle test (MMT) will be performed
according to Medical Research Council (MRC) guidelinesthat this will be a passive motion and may
uncomfortable but should not be painful.
Active movement (i) The participant lies on his or her back, lifts and
straightens one leg with a weight attached to the
ankle. The heel is lifted so that it is approximately
18 cm above the bed and held in that position
for 30 seconds. This is repeated three times
consecutively.
(ii) The participant lies on his or her back, stretches
out the knee and performs a set of 15 quadriceps
contractions keeping the leg in the same position.
This is repeat twice a day for 4 weeks.
Table 6 Summary of measures to be collected
Outcome measures Data collection instrument
Primary outcome measures
Pain Visual analogue scale (VAS)
Swelling Girth measurement
Knee range of motion Range of motion (ROM)
Muscle strength Manual muscle test (MMT)
Walking distance Six-minute walking test (6 MW)
The time to ascend and
descend a flight of stairs
Stair-climbing test (SCT)
Secondary outcomes
Pain Average daily consumption of drugs
Activities of daily living Modified Barthel index (MBI)
Quality of life Medical outcomes short form
36 health questionnaire (SF-36)
Other outcomes
Adverse events Safety assessments
Cost Economic evaluation
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grades muscle strength between 0 and 5 [31]. According
to the muscle scale, 0 = no palpable contraction, total
paralysis; 1 = flicker or trace of muscle contractions;
2 = active movement with gravity eliminated; 3 = full
range with gravity eliminated; 3– = partial range against
gravity; 3+ = full range against gravity with no resist-
ance possible; 4 = slight resistance; 4– =mild resistance;
4+ =moderate resistance; 5– = barely detectable weakness
and 5+ = normal motor power.
Walking performance will be assessed using the
six-minute walking test (6 MW). This measures the
distance that participants are able to walk in 6 minutes
while wearing their usual footwear. Patients will be allowed
to use a cane, if necessary. Standardized feedback will
be provided to patients during each test as described
previously [32]. The 6 MW test will be done twice and
the test results averaged. A longer walking distance than
baseline will indicate better walking performance. The
6 MW test has excellent test-retest reliability from 0.95
to 0.97 and a low coefficient of variation (10.4%) [33].
The stair-climbing test (SCT) is a physical perform-
ance test that measures the time it takes to ascend and
descend a flight of stairs. Patients will be asked to
complete the test as quickly as they can while still feel-
ing safe and comfortable. Patients will be allowed to use
a device if necessary, though participants will be en-
couraged to perform the test without the aid of a device if
possible. Rejeski [34] found that a similar stair-climbing
task had an excellent test–retest reliability coefficient
of 0.93.Based on the Guidelines for the Clinical Research of
Chinese Medicine New Drugs (2002) [35], the curative
effect for KOA is calculated as:
Curative effect
¼ Total score before treatment–Total score after treatmentð Þ
 100=Total score before treatment
where the total score before and after treatment is based
on the measures above.
The standard comprehensive effect:
 clinical cure: curative effect ≥ 90%
 obvious effects: 75% ≤ curative effect < 90%
 effective: 35% ≤ curative effect < 75%
 invalid: curative effect < 35%
The efficiency of a treatment is calculated as:
Efficiency %ð Þ ¼ ðNumber of clinical cures
þNumber of cases with obvious effects
þNumber of effective curesÞ
 100=Total number of cases
Secondary outcomes
The average daily consumption of non-steroidal, anti-
inflammatory drugs.
ADL performance will be assessed using the modified
Barthel index (MBI) [36], which is based on 10 items and
is scored on a scale from 0 to 100. A higher score indicates
more independence [37].
QOL will be evaluated using the medical outcomes
short form 36 health questionnaire (SF-36). The SF-36
has been found to be reliable and is easy to administer
[38-40]. The questionnaire has eight scales for different
domains of health as follows: physical functioning, bodily
pain, physical state, general health, vitality, emotional state,
social functioning and mental health. Each scale is scored
between 0 and 100 with 100 representing the best score
possible. The PCS (physical component scales, summary
scales of physical functioning, bodily pain, role-physical
and general health) in SF-36 will be the main focus of this
investigation as it is a composite of all scales representing
the physical aspects of health.
Safety assessments
Trial coordinators and therapists at each CHC will record
adverse events and the details of these events, throughout
the study and during the follow-up period. Participants
will be able to report adverse events at any time during
the trial and will receive advice accordingly. Serious
adverse events will be reported to the Human Research
Ethics Committee (HREC) of FJTCM.
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The cost of interventions will be assessed during the
rehabilitation period, including the length of any hospital
stay, emergency department visits, general medical treat-
ment, visits to a specialized physician and nursing care. The
intervention costs of high-grade hospitals will be compared
to those of CHCs. Medicare national fee structures will
be used to evaluate the costs of these services since
out-of-pocket expenses for these services often do not
accurately reflect the service value. Finally, the number
of workdays lost by participants during rehabilitation
will be used to assess indirect costs.
Statistical analysis
Statistical analysis will be conducted using SAS software
(version 8.2, SAS Institute, Cary, NC, USA). All tests
will be two-tailed with P values of less than 0.05 considered
statistically significant.
Descriptive statistics will be presented for each group
as the mean ± standard deviation and all enumeration
data will be presented as constituent ratio and rate in
the outcomes from baseline to each time point. Changes in
differences between groups in the primary and secondary
outcomes, before and after treatment and during the follow-
up period (at 4 weeks and 12 weeks), will be analyzed using
repeated measures ANOVA or a rank-sum test.
Changes in effect sizes between pre- and post-intervention
will be performed using the Wilcoxon test and chi square
test. The effect size will be evaluated with safety set (SS),
full analysis set (FAS), per-protocol set (PPS) and cost-
effectiveness analysis. Demographic and CHC charac-
teristics, as well as baseline data, will be analyzed using
the FAS to assess the baseline and CHC comparability
between groups. The primary analysis of the data will be
undertaken using FAS with the principle of intention-to-
treat and the PPS. The secondary analysis of the data will
be undertaken using PPS. To account for missing data,
multiple imputation of missing follow-up measures will be
performed per the methods used for missing data [41].
The PPS will be used to assess adherence, the SS to assess
adverse events and the cost-effectiveness analysis to assess
health economics.
Discussion
KOA is a major public health problem and this project,
funded by the State Administration of Traditional Chinese
Medicine, has two aims. First, the curative effect of
CTCMRP for KOA rehabilitation will be assessed and
CTCMRP will be examined to develop a SRPTCM for
KOA rehabilitation in China and worldwide. Secondly,
self-management for KOA patients will be improved
and their financial burden reduced.
In this study, the rehabilitation therapists will undergo
rigorous training and accreditation to administer theCTCMRP intervention. Regular meetings will be held
throughout the study to exchange views. The outcome
measures will include self-reported measures of pain,
the SF-36, QOL and activities of daily living. Knee
ROM, the 6 MW test, the stair-climbing test and the
comprehensive effect will assess functional perform-
ance, strength and physical activity levels. In addition,
a health economic assessment will be used to justify
the cost-effectiveness of treatments in the current eco-
nomic climate and a safety assessment will be done to
assess adverse events.
The biggest limitation of this protocol is that there is
no placebo control and it is not double-blinded. How-
ever, the evidence-based medicine center will be blind to
the intervention to decrease possible bias. The study also
lacks long-term follow-up and evaluation. The 4-week
intervention period reflects what is done in actual clinical
practice and is long enough to test whether a rehabilita-
tion modality is effective in the short term and whether
the efficacy is sustained during the follow-up period. Due
to ethical considerations, non-steroidal anti-inflammatory
drugs will be permitted as required.
If successful, this project offers a low-cost solution for
efficiently linking millions of hospitalized KOA patients
with effective outpatient treatment. CTCMRP rehabilitation
therapy for KOA can be done in a CHC or at home instead
of in a high-grade hospital, thus reducing the financial




6 MW: Six-minute walking test; ADL: Activities of daily living;
CHC: Community health center; CT: Conventional therapy;
CTCMRP: Comprehensive traditional Chinese medicine rehabilitation
protocol; FAS: Full analysis set; FJTCM: Fujian University of Traditional Chinese
Medicine; KOA: Knee osteoarthritis; MBI: Modified Barthel index; MMT: Manual
muscle test; MRC: Medical Research Council; PPS: Per-protocol set;
QOL: Quality of life; ROM: Range of motion; SCT: Stair-climbing test;
SF-36: Medical outcomes short form 36 health questionnaire; SRPTCM: Standard
rehabilitation protocol in TCM; SS: Safety set; TCM: Traditional Chinese medicine;
TDP: Te Ding Dian Ci Pu; VAS: Visual analogue scale.
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